Global Standardized Financials

9.71 -0.22(-2.22%)05/17/2024
Vir Biotechnology Inc (VIR)

Income Statement
(Values in USD Thousands)
 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Income-65,276-163,413-194,775-140,956
Revenue56,376-4,098-12,72246,712
Cost Of Revenue4,57638221,907
gross Profit51,800-4,136-12,74444,805
Operating Expenses104,281182,596202,442188,176
Selling General and Administrative Expenses36,27341,08047,10146,778
Research and Development Expenses68,008148,253171,860157,643
Other Expenses-287882-367-16,245
Cost And Expenses108,857182,634202,464190,083
Operating Income-52,481-186,732-215,186-143,371
Interest Income21,28321,93123,01621,307
Income Tax Expense276-3,213-2,848-2,232
Income Before Tax-65,000-166,626-197,623-143,188
Earning Per Share Basic-0.48-1.22-1.45-1.06
Earning Per Share Diluted-0.48-1.22-1.45-1.06
weighted Average Shares Outstanding135,281134,290134,059133,553
weighted Average Shares Outstanding (Diluted)135,281134,290134,059133,553
Gross Margin0.921.011.000.96
EBIT Margin-0.8544.9116.51-2.79
Profit Margin-1.1639.8815.31-3.02
EBITDA-47,964-184,025-210,100-130,268
Earning Before Tax Margin-1.1540.6615.53-3.07